MeSH term
Frequency | Condition_Probility | Adult | 63 | 0.0 |
Antibodies, Bacterial/blood | 5 | 7.0 |
Boutonneuse Fever/*diagnosis | 3 | 100.0 |
Female | 66 | 0.0 |
Humans | 149 | 0.0 |
Male | 71 | 0.0 |
Middle Aged | 39 | 0.0 |
Rickettsia conorii/immunology | 2 | 100.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
*GTP Phosphohydrolases | 3 | 33.0 |
GTP-Binding Proteins/*genetics | 2 | 1.0 |
Gene Rearrangement | 2 | 0.0 |
*Proto-Oncogenes | 4 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 53 | 0.0 |
*Transcription Factors | 4 | 0.0 |
Blood Glucose/analysis | 3 | 0.0 |
*Food | 5 | 5.0 |
Kinetics | 5 | 0.0 |
Pancreatic Polypeptide/blood | 4 | 6.0 |
Time Factors | 11 | 0.0 |
Triglycerides/blood | 3 | 0.0 |
Vagus Nerve/*physiology | 7 | 43.0 |
Animals | 27 | 0.0 |
Dogs | 3 | 0.0 |
Italy | 2 | 0.0 |
Algorithms | 3 | 0.0 |
Models, Statistical | 2 | 1.0 |
Actins/metabolism | 2 | 0.0 |
Comparative Study | 25 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Child | 14 | 0.0 |
*Medical Missions, Official | 2 | 100.0 |
Pregnancy | 4 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Radiotherapy, Conformal/*methods | 2 | 20.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Cells, Cultured | 10 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
DNA Primers | 4 | 0.0 |
Exons | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Infant | 6 | 0.0 |
Leukocyte Count | 3 | 0.0 |
Acute Disease | 4 | 0.0 |
Reproducibility of Results | 3 | 0.0 |
Retrospective Studies | 5 | 0.0 |
Sensitivity and Specificity | 5 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Breast Neoplasms/*radiotherapy | 2 | 16.0 |
Dose-Response Relationship, Radiation | 2 | 0.0 |
Radiation Tolerance | 2 | 2.0 |
Radiotherapy Dosage | 2 | 1.0 |
Radiotherapy Planning, Computer-Assisted | 2 | 16.0 |
DNA, Bacterial/analysis | 2 | 3.0 |
English Abstract | 14 | 0.0 |
Species Specificity | 4 | 0.0 |
Ticks/microbiology | 2 | 50.0 |
Molecular Sequence Data | 9 | 0.0 |
Organ Specificity | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Biomechanics | 2 | 1.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Cholecystokinin/blood | 2 | 3.0 |
Gastrins/blood | 6 | 8.0 |
Insulin/blood | 3 | 0.0 |
Adolescent | 18 | 0.0 |
Child, Preschool | 11 | 0.0 |
Predictive Value of Tests | 5 | 0.0 |
Prognosis | 2 | 0.0 |
Portugal/epidemiology | 2 | 11.0 |
Depression/*etiology/psychology | 2 | 100.0 |
Severity of Illness Index | 2 | 0.0 |
Fibroblasts/*physiology | 3 | 5.0 |
Amino Acid Sequence | 5 | 0.0 |
Base Sequence | 7 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
Transients and Migrants | 2 | 18.0 |
*Chromosomes, Human, Pair 17 | 2 | 0.0 |
*International Cooperation | 2 | 16.0 |
Treatment Outcome | 3 | 0.0 |
Analysis of Variance | 5 | 0.0 |
Pancreas/*secretion | 2 | 9.0 |
Radioimmunoassay | 2 | 0.0 |
Cattle | 4 | 0.0 |
Cell Division | 4 | 0.0 |
*Disease Outbreaks | 2 | 3.0 |
Hospitalization | 2 | 1.0 |
Mice | 8 | 0.0 |
Reference Values | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Postoperative Period | 2 | 0.0 |
*Bone Marrow Cells | 2 | 0.0 |
Growth Substances/physiology | 2 | 1.0 |
Guinea Pigs | 3 | 0.0 |
Culture Media | 4 | 0.0 |
Fibroblasts/cytology | 2 | 0.0 |
Solubility | 2 | 0.0 |
*Cell Movement | 5 | 4.0 |
Fibronectins/genetics | 2 | 6.0 |
In Vitro | 2 | 0.0 |
Aged | 19 | 0.0 |
Rickettsia/*isolation & purification | 2 | 66.0 |
Equipment Design | 2 | 1.0 |
Anti-Bacterial Agents/therapeutic use | 2 | 1.0 |
Cholecystokinin/antagonists & inhibitors/*physiology | 2 | 20.0 |
Eating | 5 | 3.0 |
Gastric Acid/*secretion | 13 | 21.0 |
Gastrins/*blood | 8 | 19.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Proglumide/analogs & derivatives/pharmacology | 2 | 8.0 |
Treatment Failure | 2 | 0.0 |
Incidence | 5 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Action Potentials/*physiology | 2 | 12.0 |
Motor Neurons/*physiology | 2 | 3.0 |
Cell Line | 6 | 0.0 |
Cell Count | 2 | 0.0 |
Cell Movement | 2 | 0.0 |
Fetus/cytology | 2 | 3.0 |
Phenotype | 2 | 0.0 |
Wound Healing/physiology | 2 | 3.0 |
Peptide Hormones/*blood | 2 | 33.0 |
Vagus Nerve/physiology | 5 | 25.0 |
Cholecystokinin/*blood | 2 | 2.0 |
Pancreatic Polypeptide/blood/*secretion | 3 | 37.0 |
Aged, 80 and over | 4 | 0.0 |
Fluorescent Antibody Technique | 6 | 0.0 |
France/epidemiology | 2 | 1.0 |
Prevalence | 3 | 0.0 |
Rickettsia/immunology | 2 | 50.0 |
Duodenal Ulcer/*physiopathology | 5 | 55.0 |
Food | 8 | 6.0 |
Pentagastrin/diagnostic use | 2 | 18.0 |
Pepsin A/*secretion | 3 | 75.0 |
Age Factors | 2 | 0.0 |
Boutonneuse Fever/*epidemiology | 2 | 100.0 |
*Fluorescent Antibody Technique | 2 | 8.0 |
Rickettsia/*immunology | 2 | 100.0 |
Sex Factors | 3 | 0.0 |
Eating/physiology | 2 | 3.0 |
Gastric Acid/secretion | 6 | 13.0 |
Blotting, Western | 2 | 0.0 |
Motilin/*blood | 2 | 50.0 |
Cell Movement/physiology | 3 | 1.0 |
Chromatography, Gel | 2 | 0.0 |
Cytokines/*physiology | 2 | 1.0 |
Cell Migration Inhibition | 3 | 2.0 |
Chronic Disease | 2 | 0.0 |
Macrophages/*immunology | 4 | 1.0 |
Fetus | 2 | 0.0 |
*Eating | 5 | 8.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Temperature | 2 | 0.0 |
Cell Movement/drug effects | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Rickettsia conorii/genetics/*isolation & purification | 2 | 100.0 |
Embryo | 2 | 0.0 |
Skin/cytology | 2 | 1.0 |
Lymphocyte Activation | 2 | 0.0 |
Lymphocytes/*immunology | 2 | 0.0 |
Rats | 2 | 0.0 |
Duodenal Ulcer/*blood | 2 | 66.0 |
Gastric Acidity Determination | 2 | 9.0 |
Pancreatic Polypeptide/*blood | 2 | 10.0 |
Pepsin A/secretion | 3 | 50.0 |
Recurrence | 3 | 0.0 |
Pentagastrin/pharmacology | 2 | 18.0 |
Catecholamines/*blood | 2 | 6.0 |
Gastrins/*secretion | 2 | 28.0 |
Secretory Rate/drug effects | 2 | 2.0 |
Atropine/pharmacology | 3 | 7.0 |
Vagotomy | 3 | 21.0 |
Gastric Juice/*secretion | 4 | 36.0 |
Adenocarcinoma/*immunology | 2 | 5.0 |
*Cell Migration Inhibition | 2 | 5.0 |
Macrophage Migration-Inhibitory Factors/biosynthesis | 2 | 18.0 |
Immunity, Cellular | 3 | 0.0 |
Macrophages/immunology | 2 | 0.0 |
Photic Stimulation/methods | 2 | 8.0 |
